CLINICAL_TRIALS
trial_result
· 2021-03-17
Clinical Trial Update: Mesenchymal Stem Cell Therapy for Liver Cirrhosis [Phase 1, Phase 2]
Summary
A clinical trial update on mesenchymal stem cell therapy for liver cirrhosis across Phase 1 and Phase 2.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Stem Med Pte. Ltd. | Conditions: Liver Cirrhosis | Phase 1, Phase 2 | Status: UNKNOWN